WESCAP Management Group Inc. Buys 370 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

WESCAP Management Group Inc. raised its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 2.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 17,947 shares of the company’s stock after acquiring an additional 370 shares during the quarter. WESCAP Management Group Inc.’s holdings in Prestige Consumer Healthcare were worth $1,236,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. GHP Investment Advisors Inc. lifted its holdings in Prestige Consumer Healthcare by 1.1% during the 2nd quarter. GHP Investment Advisors Inc. now owns 86,540 shares of the company’s stock valued at $5,958,000 after purchasing an additional 928 shares during the last quarter. BOKF NA increased its holdings in Prestige Consumer Healthcare by 120.9% during the 2nd quarter. BOKF NA now owns 7,584 shares of the company’s stock valued at $522,000 after purchasing an additional 4,150 shares in the last quarter. Choreo LLC bought a new position in Prestige Consumer Healthcare in the 2nd quarter valued at $677,000. Quest Partners LLC boosted its stake in Prestige Consumer Healthcare by 2,826.7% in the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock worth $30,000 after purchasing an additional 424 shares in the last quarter. Finally, Norden Group LLC grew its holdings in shares of Prestige Consumer Healthcare by 25.9% during the second quarter. Norden Group LLC now owns 12,435 shares of the company’s stock worth $856,000 after purchasing an additional 2,559 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on PBH shares. StockNews.com downgraded shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. Canaccord Genuity Group reiterated a “buy” rating and set a $80.00 target price on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. Finally, DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and a consensus price target of $98.75.

Prestige Consumer Healthcare Stock Performance

PBH stock opened at $74.12 on Friday. Prestige Consumer Healthcare Inc. has a twelve month low of $56.34 and a twelve month high of $75.80. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. The company has a market cap of $3.67 billion, a P/E ratio of 17.77, a price-to-earnings-growth ratio of 2.01 and a beta of 0.48. The business’s fifty day moving average is $70.77 and its 200-day moving average is $69.56.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. During the same period in the prior year, the company earned $1.06 earnings per share. The company’s revenue for the quarter was down 4.4% compared to the same quarter last year. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.